Insights

Strategic Acquisition Expansion Chiesi's recent acquisition of Amryt Pharma for 1.25 billion dollars indicates a strategic focus on expanding its portfolio, particularly in the rare disease segment, presenting opportunities for partners providing specialized therapies or integrated solutions in rare and niche markets.

Robust R&D Presence With seven research centers dedicated to innovative drug development, Chiesi is investing heavily in breakthrough therapies, creating openings for technology providers, contract research organizations, and scientists seeking collaborations in cutting-edge pharmaceutical research.

Global Market Penetration Operating in over 100 countries with a significant international workforce, Chiesi offers ample opportunities for distributors, logistics providers, and regional sales partners aiming to expand presence in Europe, North America, and emerging markets.

Focus on Respiratory and Rare Diseases Specializing in respiratory, neonatology, and rare diseases, the company presents tailored opportunities for medical device manufacturers, diagnostic companies, and specialty pharma seeking to address these high-growth therapeutic areas.

Sustainable Growth Strategy Chiesi’s emphasis on social and environmental responsibility aligns with partners committed to sustainable practices, particularly those offering eco-friendly manufacturing, packaging, or corporate social responsibility solutions, to support their mission and brand positioning.

Chiesi Italia Tech Stack

Chiesi Italia uses 8 technology products and services including Font Awesome, Modernizr, OWL Carousel, and more. Explore Chiesi Italia's tech stack below.

  • Font Awesome
    Font Scripts
  • Modernizr
    Javascript Libraries
  • OWL Carousel
    Javascript Libraries
  • PHP
    Programming Languages
  • X-XSS-Protection
    Security
  • Bootstrap
    UI Frameworks
  • Apache
    Web Servers
  • Twitter
    Widgets

Chiesi Italia's Email Address Formats

Chiesi Italia uses at least 2 format(s):
Chiesi Italia Email FormatsExamplePercentage
First.Last@chiesi.comJohn.Doe@chiesi.com
59%
F.Last@chiesi.comJ.Doe@chiesi.com
29%
FirstLast@chiesi.comJohnDoe@chiesi.com
8%
FLast@chiesi.comJDoe@chiesi.com
2%
L.First@chiesi.comD.John@chiesi.com
1%
FirstLa@chiesi.comJohnDo@chiesi.com
1%
FLast@chiesi.itJDoe@chiesi.it
87%
F.Last@chiesi.itJ.Doe@chiesi.it
13%

Frequently Asked Questions

What is Chiesi Italia's official website and social media links?

Minus sign iconPlus sign icon
Chiesi Italia's official website is chiesi.it and has social profiles on LinkedIn.

How much revenue does Chiesi Italia generate?

Minus sign iconPlus sign icon
As of December 2025, Chiesi Italia's annual revenue is estimated to be $5B.

What is Chiesi Italia's NAICS code?

Minus sign iconPlus sign icon
Chiesi Italia's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Chiesi Italia have currently?

Minus sign iconPlus sign icon
As of December 2025, Chiesi Italia has approximately 5K employees across 6 continents, including EuropeAsiaAfrica. Key team members include Ceo And Managing Director At Chiesi Italia S.P.A: R. I.Ceo & Management Director Assistant: V. A.Head Of Marketing Care: B. B.. Explore Chiesi Italia's employee directory with LeadIQ.

What industry does Chiesi Italia belong to?

Minus sign iconPlus sign icon
Chiesi Italia operates in the Pharmaceutical Manufacturing industry.

What technology does Chiesi Italia use?

Minus sign iconPlus sign icon
Chiesi Italia's tech stack includes Font AwesomeModernizrOWL CarouselPHPX-XSS-ProtectionBootstrapApacheTwitter.

What is Chiesi Italia's email format?

Minus sign iconPlus sign icon
Chiesi Italia's email format typically follows the pattern of First.Last@chiesi.com. Find more Chiesi Italia email formats with LeadIQ.

When was Chiesi Italia founded?

Minus sign iconPlus sign icon
Chiesi Italia was founded in 1935.

Chiesi Italia

Pharmaceutical ManufacturingEmilia-romagna, Italy5001-10000 Employees

Nata a Parma nel 1935 come piccolo laboratorio di provincia, Chiesi pur conservando un forte radicamento in Italia, è oggi un gruppo biofarmaceutico internazionale che conta oltre 6.500 persone, 31 filiali, 7 centri di ricerca, 3 siti produttivi e un fatturato di oltre 2 miliardi di euro.

In oltre 85 anni di storia e tre generazioni, l’azienda ha incentrato le sue attività sulla ricerca, sviluppo, produzione e commercializzazione di soluzioni terapeutiche innovative, sviluppando farmaci di successo distribuiti in oltre 100 Paesi. Le aree terapeutiche principali sono quella respiratoria, neonatologia, medicina specialistica e malattie rare, da sempre ambito di eccellenza del Gruppo.

La nostra missione
Vogliamo essere riconosciuti come Gruppo internazionale incentrato sulla ricerca, in grado di sviluppare e commercializzare soluzioni terapeutiche innovative che migliorino la qualità della vita delle persone.
Intendiamo mantenere un team imprenditoriale di elevata qualità, caratterizzato da spirito di collaborazione e sicurezza in se stesso. 
Il nostro obiettivo è unire impegno verso i risultati e integrità, operando con responsabilità sia dal punto di vista sociale, sia da quello ambientale.

Carriera in Chiesi
Chiesi offre numerose opportunità di carriera, in Italia e all'estero, a giovani talenti interessati a lavorare nel farmaceutico. L’obiettivo è selezionare persone meritevoli e di valore e aumentare il loro talento offrendo l’opportunità di esprimere pienamente le proprie energie e potenzialità.

Section iconCompany Overview

Website
chiesi.it
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1935
Employees
5001-10000

Section iconFunding & Financials

  • $500M$1B

    Chiesi Italia's revenue is estimated to be in the range of $500M$1B

Section iconFunding & Financials

  • $500M$1B

    Chiesi Italia's revenue is estimated to be in the range of $500M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.